CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 98 enrolled
Drug / intervention
Lidocaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03107754
NCT03107754Phase 4Completed

Buffered Lidocaine for Paracervical Block to Decrease Injection Pain During First Trimester Uterine Aspirations

University of Hawaii·interventional·Posted Apr 11, 2017·Updated Jan 5, 2021

In Brief

A Phase 4 clinical trial evaluating Lidocaine and Lidocaine-Sodium Bicarbonate for Pain. Completed, enrolled 98 participants across 1 site.

Detailed Summary

For pain relief during a first trimester surgical aspiration, most providers use the paracervical block, either alone or in combination with other pain control techniques. Some providers use buffered lidocaine due to a belief that it decreases pain. Others use plain lidocaine. At our clinics, the standard pain management protocol is using 20 cc of 1% plain lidocaine in a two site injection. Few studies have compared buffered versus unbuffered lidocaine for paracervical blocks during first trimester uterine aspirations. This study seeks to determine if buffered lidocaine decreases injection pain versus plain lidocaine for paracervical blocks.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedApr 11, 2017
Enrollment StartMay 15, 2017
Primary CompletionOct 25, 2018
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 9.2 years ago

Interventions

Lidocainedrug

Paracervical block will be injected at 2 points at the cervicovaginal junction to decrease pain

Lidocaine-Sodium Bicarbonatedrug

Paracervical block will be injected at 2 points at the cervicovaginal junction to decrease pain